We are live on ! Find out more
VP

venBio Partners Portfolio holdings

AUM $519M
1-Year Est. Return 339.42%
This Fund
S&P 500
This Quarter Est. Return
-30.28%
1 Year Est. Return
+339.42%
3 Year Est. Return
+563.8%
5 Year Est. Return
+1,003.88%
10 Year Est. Return
–
AUM
$38.1M
AUM Growth
-$19.1M
Cap. Flow
-$4.36M
Cap. Flow %
-11.45%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
APLS
Apellis Pharmaceuticals
APLS
+$27.5M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APLS
1
DELISTED
Apellis Pharmaceuticals
APLS
$23.6M 62.01%
+1,790,102
New +$27.5M
VRNA
2
DELISTED
Verona Pharma
VRNA
$8.44M 22.18%
875,000
– –
YARW
3
Yarrow Bioscience
YARW
$98.8M
$6.02M 15.82%
406
– –

Similar funds

CFA
Churchill Financial Advisors Louisville, Kentucky $519M AUM
CFG
Compton Financial Group Towson, Maryland $519M AUM 14.76% 1-Year Est. Return
MWM
Mindset Wealth Management Indianapolis, Indiana $519M AUM 46.03% 1-Year Est. Return
SWM
Scissortail Wealth Management Tulsa, Oklahoma $520M AUM 21.73% 1-Year Est. Return
WS
Wendel SE Paris $519M AUM 48.2% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
MWC
MBM Wealth Consultants Chesterfield, Missouri $519M AUM 16.88% 1-Year Est. Return
PDIP
Palo Duro Investment Partners Chicago, Illinois $518M AUM 22.62% 1-Year Est. Return

venBio Partners's Q4 2018 Portfolio in Review

As of Q4 2018, venBio Partners held 4 positions worth $38.1M, down 33% from $57.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

venBio Partners withdrew a net $4.36M in Q4 2018, closing 1 position.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 44% a quarter earlier.

Against the trend, venBio Partners opened a new position in Apellis Pharmaceuticals worth $23.6M.

  • venBio Partners's largest Q4 2018 buy was Apellis Pharmaceuticals: 1,790,102 shares worth $23.6M.
  • venBio Partners's ten largest holdings make up 100% of its $38.1M portfolio in Q4 2018.
  • venBio Partners opened 1 new position and closed 1 in Q4 2018.
  • venBio Partners's portfolio value fell 33% quarter-over-quarter to $38.1M.

Based on venBio Partners's 13F filing for Q4 2018, filed 14 Feb 2019.